Introduction
Organ development and homeostasis depend on the proper balance between self-renewal and differentiation of stem cells. However, this balance can be shifted due to the susceptibility of self-renewing stem cells to oncogenic transformation, leading to uncontrolled proliferation associated with cancer. In Author Manuscript Published OnlineFirst on July 7, 2017; DOI: 10.1158/0008-5472. through the induction of cell cycle arrest, cellular senescence or apoptotic cell death (4) (5) (6) . However, how these tumor suppressors are activated in NSCs of the adult brain to prevent oncogenic transformation and the propagation of malignant cells is not fully understood.
The HMG-box SOX transcription factor family members SOX5, SOX6 and SOX21 are widely expressed in NSCs of the CNS (7) (8) (9) (10) (11) (12) and when overexpressed can promote embryonic NSCs to exit the cell cycle and commit to differentiation (13, 14) . Interestingly, a common feature of these SOX transcription factors is their capability to counteract tumor cell expansion, as in vitro experiments have shown that forced expression of SOX5 and SOX21 decreases the viability of human glioma cell lines (15, 16) . Although SOX6 has not been reported to alter the self-renewal of brain tumor cells, cell culture-based studies have shown that overexpression of SOX6 can suppress the expansion of non-CNS tumor cell lines (17) (18) (19) . Despite these overexpression studies suggesting that SOX5, SOX6 and SOX21 can counteract cancer cell propagation, the question whether these transcription factors can also prevent malignant transformation of NSCs in the brain, has yet to be addressed.
Here we have examined the role of SOX5, SOX6 and SOX21 (SOX5/6/21) in NSCs of the adult mouse subventricular zone (SVZ) upon oncogenic stress. We show that SOX5/6/21 are necessary for SVZ cells to induce an anti-tumorigenic response to oncogenes and that the susceptibility of these cells to initiate the formation of glioma-like tumors is strongly increased by the individual or combined removal of the Sox5/6/21 genes. 
Materials and Methods

Generation of mutant mice and tumor induction
All animal procedures and experiments were performed in accordance with Swedish animal welfare laws authorized by the Stockholm Animal Ethics committee: Dnr N249/14. Generation of Sox5 flox/flox and Sox6 flox/flox mice has been described previously (20, 21) . C57BL/6J mice were used as wild type controls.
For lentiviral injections, 10-20 week old mice were used for the experiments.
Animals received stereotactially guided injections over 3-5 min into the SVZ (1.5 mm lateral and 0.6 mm anterior to bregma; depth 1.5 mm from dura) of 2 µL virus mix of HRAS, AKT and CRE. Mice were sacrificed up to 6 months after viral injections. For transplantation of human GBM cells, NOD.CB17-PrkcSCID/J mice of 6-10 weeks-of-age were used. 100,000 cells were transplanted stereotactically into striatum (2.0 mm lateral and 1.0 mm anterior to bregma; depth 2.5 mm from dura). Mice were sacrificed 3 months post-transplantation. Tumor size was calculated as an arbitrary value of GFP area at the same anterior-posterior level of multiple animals, using ImageJ.
Cell culture
Glioblastoma tissue specimens were collected via surgical resection under the 7 established from fresh tumor tissue using papain (Worthington) following manufacturer's protocol, or obtained from collaborators. Cells were cultured on poly-L-ornithine and Laminin (Sigma-Aldrich) coated plates in Human NeuroCult TM NS-A Proliferation media (Stem Cell Technology) supplemented with 2 µg/mL heparin (Stem Cell Technology), 10 ng/ml FGF (Stem Cell Technology), 20 ng/ml EGF (Stem Cell Technology) and PenStrep (Gibco). All primary cells were used below passage 15. U87 cell line, purchased from ATCC 2013, was cultured in Dulbeco Modified Eagle Medium containing glucose and glutamine (GIBCO), supplemented with 10 % FBS (Stem Cell Technology) and 100 g/ml Penstrep (GIBCO). U87 cell line was used between passage 5-10 (from arrival in the lab) and has not been authenticated since purchase. Cells from the adult mouse SVZ were collected as previously described (23) and tissue was disected using papain (Worthington) following manufacturer's instructions. SVZ cells were cultured in mouse NeuroCult TM NS-A Proliferation media (Stem Cell Technology) according to manufacturer's protocol. Neurospheres were maintained in ultra-low attachment surface plates (Corning). All cell cultures were regularly tested for mycoplasma with MycoAlert luciferase assay (Lonza) whereby the last set of assays was performed in September of 2016.
Neurosphere forming assays
Neurosphere formation capacity assay was conducted as previously described (24) and neurospheres subjected to size measurement using publically available ImageJ software.
Lentiviral vectors and virus production
Research. 
Lentiviral transductions and plasmid transfections
Lentiviral transductions of cells were performed at a MOI of 1-2. Transduced cells were kept in culture for 3 days (proliferation assay), 3-9 days (senescence assay and western blot analysis) and 9-12 days (AnnexinV assay), before being subjected to an assay of interest. Transfection of GBM cells was conducted using the NEON transfection system (Thermo Fisher Scientific), following manufactures protocol. Transfected cells were kept in culture for 3 days, before undergoing a proliferation assay. 
Proliferation, senescence and cell death assays
Accession numbers
The NCBI Sequence Read Archive accession number for the sequencing data reported in this paper is SRP109992.
Statistical analyses
Statistical analyses were performed when appropriate and P values indicated by an asterisk in the figure legends. Significant differences between means for single comparisons were determined via Student's t-test. Multiple comparison analyses were conducted using ANOVA, followed by Bonferroni's correction for post-hoc analysis. NS stands for not significant.
Additional description of Materials and Methods can be found in the Online supplemental material.
Results
SOX5/6/21 expression is increased in brain NSCs upon oncogenic stimuli
To address the role of SOX5, SOX6 and SOX21 in brain NSCs upon oncogenic stress, we first defined their expression pattern and activity in NSCs of the adult mouse SVZ, which have been shown to be susceptible to oncogenic transformation (24) (25) (26) . In this region of the brain, a vast majority of the SOX2 + and NESTIN + progenitor cells expressed SOX5/6/21, and their expression could be detected in most self-renewing KI67 + cells (Figs. 1A-K) . Overexpression of SOX5, SOX6 or SOX21 promotes cell cycle exit of embryonic NSCs (13, 14) ( Supplementary Fig. S1A 
Deletion of Sox5/6/21 potentiates the formation of glioma-like tumors
The anti-proliferative activity of SOX5/6/21 and the observation that their expression levels were increased in NSCs transduced with ARC-expressing lentiviruses, raise the possibility that these proteins may be part of a cellular response mechanism, which counteracts oncogenic transformation of NSCs. To examine this possibility, we analyzed how the tumor-inducing capacity of AKT and H-RAS, in NSCs of the adult brain was affected by the loss of SOX5/6/21 expression. Lentiviruses expressing ARC (Fig. 1N) were injected into the SVZ ( (Fig. 3A-E) . Moreover, while we could not detect any significant increase in the volume of the neurospheres generated by Sox5/6 mutant cells, of 998 genes. Consistent with the findings above, gene ontology (GO) analysis of the deregulated genes revealed a significant upregulation of proliferationassociated genes, resulting in high enrichment of GO-terms such as "Mitotic cell cycle", "Cell division" and "RB in cancer" (Fig. 3L) . In contrast, analysis of the downregulated genes resulted in a strong enrichment of GO-terms associated with cellular differentiation, such as "Neurogenesis", "Gliogenesis" and "Axon guidance pathway" (Fig. 3M) Fig. S3A ).
However, in the presence of AKT and H-RAS expression, the loss of Sox5/6/21 lead to a dramatic increase in Cyclin levels (Fig. 4A) . Cells expressing ARC responded differently to the loss of Sox5, Sox6 and Sox21. While the upregulation of CyclinD2 and CyclinE1 levels were predominately associated with the loss of Sox21, the most significant increase in CyclinA1 levels was detected in Sox5/6 mutant cells (Fig. 4A) . Even though the level of total RB remained unchanged, the level of the inactive, hyperphosphorylated form of this protein (pRB) followed that of the Cyclins, and was highly increased in ARC-expressing cells mutant for Sox5/6, Sox21 and Sox5/6/21 (Fig. 4B) 
the loss of Sox5/6/21 did not lead to a significant change in pRB levels ( Supplementary Fig. S3B ). Moreover, although the protein levels of the CDK inhibitors p21, p27, p57 and the tumor suppressor p53 were increased in SVZ upon AKT and H-RAS expression (Supplementary Fig. S3C ), this upregulation was completely abolished following the loss of Sox5/6/21 (Fig. 4C) . In the absence of oncogene expression, the lack of Sox5/6/21 did not lead to detectable decrease in protein levels of CDK inhibitors or p53 (Supplementary Fig. S3D ).
Notably, a corresponding regulation of the cell cycle regulators analyzed above could not be detected at the mRNA levels (Supplementary Table 2 (Fig. 5H) , GBM cells misexpressing either SOX5, -6 or -21, failed to form secondary tumors upon transplantation ( Fig. 5I-K) . Thus, apart from preventing mouse SVZ cells from malignant transformation, SOX5/6/21 can also reduce proliferation and the tumor-inducing capacity of human primary GBM cells.
SOX5/6/21 can restore tumor suppressor responses in human GBM cells
The fact that increased levels of SOX5/6/21 counteract proliferation of human Fig. S5A ).
The transduced cells responded to SOX5/6/21 expression by deregulating thousands of genes (1.5 fold) ( Fig. 6A; Supplementary Fig. S5B) . Comparisons of the up-and downregulated genes revealed a significantly higher overlap between the genes deregulated by SOX5 and SOX6, compared with the genes deregulated by SOX21 ( Fig. 6B; Supplementary Fig. S5C ). GO-term analysis of genes deregulated by SOX5/6/21 in the primary and the established GBM cell lines, KS4 and U87, revealed a strong repression of proliferation-associated genes, resulting in an enrichment of GO-terms, including "Mitotic cell cycle", "Nuclear division" and "RB in cancer" (Fig. 6C; Supplementary Fig. S5D ).
Interestingly, analysis of the genes upregulated by SOX5/6/21 instead resulted in a significant enrichment of GO-terms associated with general tumor suppressor responses, including "Apoptotic process", "Cellular response to stress" "Direct p53 effector" and "Senescence and Autophagy" (Fig. 6C; Supplementary Fig.   S5D ). 7A-E). The observation that the presence of p53 protein appears to be central for the capacity of SOX21 to facilitate a tumor suppressor response in GBM cells, raises the question of how SOX21 promotes the increase in p53 levels. Notably, despite a robust increase in p53 protein levels upon forced SOX21 expression ( Fig. 6D; Figs. 7A and B) , a corresponding upregulation of TP53 gene expression could not be detected (Supplementary Fig. S6A ). In fact, while the protein levels of CDK inhibitors (p16, p21, p27, p57) and p53 were increased in response to SOX21 overexpression ( Fig. 6D; Figs. 7A and B 
of SOX21 to upregulate p16, p27 and p53 appears mainly to be achieved at the protein level.
We next examined if SOX21-driven upregulation of p53 is achieved through an ability to stabilize this tumor suppressor on a protein level (47) . Indeed, SOX21 markedly extended the half-life of p53 protein in human primary GBM cells (#87) and the glioma cell line U87 after protein synthesis inhibition by cycloheximide (CHX) (Fig. 7F and G) . SOX21 misexpression in these cells also resulted in the upregulation of phosphorylated (Ser15) p53, which is a stable form of this protein ( Fig. 7H and I) . Moreover, the level of the ubiquitin-protein ligase, MDM2, which is a negative regulator of p53 (48), was significantly reduced in GBM cells overexpressing SOX21 (Fig. 7J and K) . However, SOX21 failed to downregulate MDM2 mRNA (Supplementary Fig. S6J ) and neither could we detect any binding of SOX21 to the MDM2 gene (Supplementary Table 3 ).
Together these data show that SOX21 can in part restore initiation of a tumor suppressor response in GBM cells by counteracting p53 protein turnover, possibly through the regulation of MDM2 protein levels (Fig. 7L) .
Discussion
Stem cells in the adult body are essential for the maintenance of organ integrity, plasticity and homeostasis (49) , but their presence also constitutes a potential risk, as stem cells are faced with the difficult task of avoiding premature cell cycle exit and at the same time being prepared to escape uncontrolled proliferation associated with neoplasia. In this study we have examined the role Research. 
